剖腹产与乳腺癌的关联:系统性审查和元分析
Foteini Stamou1, Anastasia Bothou1, Giannoula Kyrkou1
1Department of Midwifery, School of Health and Care Sciences, University of West Attica, 12243 Athens, Greece.
Molecular and clinical oncology
|September 29, 2025
概括
剖腹产 (CS) 可能会略微增加乳腺癌 (BC) 的风险,尤其是侵袭性形式. 然而,证据是不一致的,需要进一步的研究来证实联系,并了解潜在的机制.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 生殖健康 生殖健康
背景情况:
- 乳腺癌 (BC) 是全球女性的主要恶性瘤.
- 研究生殖因素,包括剖腹产 (CS),以确定BC风险.
- CS和BC风险和预后之间的关联正在受到越来越严格的审查.
研究的目的:
- 系统地审查和评估CS和BC风险之间的关联.
- 评估CS在乳腺癌患者的预后影响.
- 综合现有文献中关于CS和BC的发现.
主要方法:
- 按照PRISMA指南进行系统的文献搜索.
- 包括四项研究,涉及1,492,962名女性.
- 进行元分析以确定BC发病率和预后因素的合并几率比率.
主要成果:
- 关于CS和BC风险的研究中存在不一致的发现.
- 分析显示,与CS史有关的BC发病率略有显著增加 (OR=1.26).
- 在BC (OR=2.11) 中,CS病史与囊外延伸的更高概率有关,但与淋巴血管侵袭无关.
结论:
- 目前关于CS和BC风险的证据是不确定的,一些研究表明适度增加.
- 在BC患者中,CS可能与更具侵略性的瘤特征有关.
- 需要进一步的大规模前性研究来澄清关联和机制.
相关概念视频
Cancer Survival Analysis
648
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
648
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
407
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
407


